• Amazon was reported working for at-home fertility tracker and monitoring device for past four years, part of the project named ‘Encore’.
  • The laid off employee are supported by Amazon until they find other opportunities within or outside Amazon.

What happened

Amazon has halted a covert attempt to create an at-home fertility tracker along with the monitoring device for a project. The anonymous insiders claimed that the corporation had been working on a project codenamed “Encore” for the last four years for the launch of a fertility monitoring gadget and related smartphone app. According to the sources, the group worked at Amazon’s Special Projects section, which is also referred to as Crown Challenge.

In October, Amazon announced that the tracker team would be disbanded. According to paperwork, those layoffs will continue to be paid by Amazon until December 27 but won’t be expected to work during that period.

“We regularly review our businesses to ensure we focus on areas where we can make the biggest difference for customers,” Callahan said. “Following a recent review, we’ve decided to discontinue this project within Grand Challenge, and we’re working directly with employees whose roles are impacted to support them through the transition and help them find other opportunities within Amazon.”

Also read:Amazon bets on nuclear power to fuel future data center growth
Also read:Amazon challenges Nvidia to offer free computing resources

Why it’s important

Amazon’s secret project to develop at-home fertility trackers and monitoring devices was shut down due to various challenges. The initiative aimed to create a consumer-friendly device that tracks ovulation and other fertility metrics at home. Despite initial promise, the project faced hurdles related to device accuracy, regulatory concerns, and competition. Amazon struggled to deliver consistent, reliable data, a key factor for users seeking fertility insights. The regulatory environment also posed significant challenges, as health-related products require rigorous testing and approvals.

The project competed against well-established fertility tech companies already dominating the market. Amazon’s ambitious attempt highlighted its interest in health tech but also revealed the difficulty of entering a complex, regulated industry. The company reportedly shifted resources to focus on other health-related innovations. The failure of the fertility tracker project reflects broader challenges in developing effective, consumer-ready health tech solutions that meet user needs and regulatory standards. Despite the setback, Amazon continues exploring other health and wellness innovations in their other challenge projects.